Related by context. All words. (Click for frequent words.) 76 Novartis Organon 76 Submits Biologics License Application 75 ExxonMobil Fluor 75 Genentech Wyeth Pharmaceuticals 75 Sign Licensing Agreement 74 Presents Positive 74 Initiates Clinical Trial 74 sanofi aventis Bayer Schering 74 Boehringer Ingelheim MedImmune 74 Sanofi Aventis Schering Plough 73 Bristol Myers Squibb Celgene 73 IG HCR ;) CO 73 Initiates Phase II 73 Genentech GlaxoSmithKline 73 Enrolls First 73 Merck OSI Pharmaceuticals 73 Announce License Agreement 73 Reveals Positive 73 Receives Milestone Payment 73 PROFILE CO 73 Announces Tentative Approval 73 Launches Generic Version 72 Initiates Enrollment 72 Merck Serono Nycomed 72 Completes Patient Enrollment 72 Licenses Novel 72 Settle Patent Dispute 72 AUDIO PROVIDED BY 72 Namenda Memantine HCl 72 Harris Hitachi Leapfrog 72 Announce Collaboration 72 Completes Enrollment 71 Bearish Average Crossover 71 Bristol Myers Squibb sanofi 71 Philips Sagem 71 Receives Orphan Drug Designation 71 Announce Merger Agreement 71 Bullish Average Crossover 71 Announce Licensing Agreement 71 Files IND 71 Submits Application 71 Boosts Estimates 71 Initiates Phase III 71 Receives FDA Clearance 71 Receives Favorable 71 Bullish Technical Alert 71 Sign License Agreement 71 Pharma Merck Serono 71 Receives Approvable Letter 71 Announces Initiation 71 Samsung Sendo 71 Puts Purchased 71 Cephalon GlaxoSmithKline 71 Calls Purchased 71 Trend Continues Down 71 Completes Tender Offer 71 Develops Innovative 70 Bullish Speculation 70 Submits NDA 70 Announces License Agreement 70 Receives Tentative Approval 70 Successfully Completes Acquisition 70 Therapeutic Competitors Companies 70 Completes Merger With 70 Successfully Completes Tender Offer 70 Announce Definitive Agreement 70 Earnings Postmortem 70 Announces Presentation 70 Bearish Speculation 70 FDA Clears 70 Bearish Technical 70 Unanimously Recommends Approval 70 Launches Next Generation 70 Welcomes Analyst Initiation 70 BioSante Pharmaceuticals Announces 70 Q2 Profit Rises 69 Announces Divestiture 69 GlaxoSmithKline Genentech 69 Announce Initiation 69 Signs Licensing Agreement 69 Files Shelf Registration Statement 69 Strengthens Position 69 Stockholders Approve Acquisition 69 Gets FDA Clearance 69 Moving Average Crossover Alert 69 Submits IND 69 Trend Continues Lower 69 Technicals Showing Bearish 69 Stocks Decline Paced 69 Acquirer Company 69 Introduces Next Generation 69 Signs License Agreement 69 Movers Roundup 69 Finalizes Acquisition 69 Announces FDA Clearance 69 Q1 Profit Rises 69 Options Trader Alert 69 Stocks Decline Led 69 NewsBite Downgrade Puts Pressure 69 Announce Collaboration Agreement 69 Collaborates With 69 Extend Collaboration 69 Receives Patent 69 Introduces Enhanced 69 Completes Purchase Of 69 SWOT Analysis Aarkstore Enterprise 69 Amends Agreement 69 #.# [026] 69 Delivers Next Generation 69 Bearish Harami Pattern 69 Bullish Harami Pattern 69 Bullish Engulfing Pattern 68 Winning Streak Continues 68 Finalizes Sale 68 Expand Relationship 68 Genentech sanofi aventis 68 COMUNICADO DE 68 Interesting Options Volume 68 Zacks Analyst Blog Highlights 68 Receives Fast Track 68 # AMC 68 Raytheon Rockwell Collins 68 Settle Patent Litigation 68 Submits Response 68 Settles Litigation 68 estrogen receptor beta agonist 68 Director Exercises Options 68 Shareholders Approve Acquisition 68 Enters Agreement 68 Initiates Dosing 68 Observation Features 68 Expand Collaboration 68 Earns Milestone Payment 68 Unveils Latest 68 Jointly Develop 68 Submits Supplemental 68 3Q Profit Rises 68 Announces Licensing Agreement 68 Announces Discontinuation 68 S. Arzerra 68 Commences Phase III 68 2hours #mins #.#secs M 68 Canaccord Genuity Maintains Hold 68 Obtains Exclusive Rights 68 Previews Earnings 68 Completes Acquisitions 68 1hour #mins #.#secs M 68 FDA Accepts 68 Commercializes 68 Downtrend Spotted 68 Announce Receipt 68 Jumps Higher 68 Stocks Advance Paced 68 Mutually Agree 68 Q3 Profit Surges 68 Q1 Loss Narrows 68 Therapeutic Competitors Report 68 Stocks Rise Paced 68 Q4 Loss Narrows 68 Voluntarily Withdraw 68 Announce Availability 68 Jaiprakash Associates Tata Steel 68 Downgrade Alert Watch 68 CHEAP ONLINE PHARMACY LOW 68 Declares Dividend Increase 68 Announce Expanded 68 Marcus Gronholm BP 68 Obtains Approval 68 Hematology Molecular Pathology 68 Q1 Adj 68 Receives Complete Response 68 Plicera TM 68 Receives Clearance 68 Extends Collaboration 68 SHIPPED THOUGH THE 68 Technicals Showing Bullish 68 Q3 Profit Rises 68 Launches Enhanced 68 'S BUY RECOMMENDATION 68 Eli Lilly GlaxoSmithKline 68 Hormel Foods Monoprix PETCO 68 Closes Acquisition Of 68 Announce Agreement 68 COMPLETES ACQUISITION OF 68 Gets Bearish Confirmation 68 Peru Movicom 67 Declares Qtr 67 R MSCRAMM 67 Expands Portfolio 67 AstraZeneca PLC Bristol Myers 67 Reports Receipt 67 Lockheed Martin Magna Steyr 67 Earnings Scorecard 67 Fourth Quarter Earnings Preview 67 developing Surfactant Replacement 67 Q1 Profit Surges 67 Secures Contract 67 Agonist MABA program 67 Announce Reseller Agreement 67 Q1 Loss Widens 67 CONFERENCE CALLS SOURCE 67 Presents Preclinical Data 67 INDICATED LOWER 67 Unveils Innovative 67 Q2 Loss Narrows 67 Concludes Acquisition 67 Benzinga Volume Movers 67 Completes Acquisition 67 Johnson Controls Lear 67 Therapeutic Competitors companiesandmarkets.com adEgemonye 67 Renews Agreement 67 Releases Next Generation 67 Announces Definitive Agreement 67 Announce Settlement 67 Bearish Moving Average 67 Completes Divestiture 67 Nasdaq XTLB 67 Unveils Next Generation 67 sanofi aventis GlaxoSmithKline 67 Stockholders Approve Merger 67 Nasdaq AMLN Eli Lilly 67 Reduces Risk 67 Extends Tender Offer 67 Reacquires 67 Wins Approval 67 Buyers Accumulating Shares 67 Approaching Resistance 67 Broadcom CooperVision Dell 67 Nasdaq MNKD focuses 67 Stocks Gain Paced 67 Bearish Pressure Building 67 Options Activity 67 Terminates Agreement 67 Post Earnings Checkup 67 Stock Upgraded 67 Announces Organizational Changes 67 PRN FDA Approves 67 Announces Early Termination 67 Introduces Expanded 67 Announce Joint Venture 67 Bullish Moving Average 67 Inks Deal With 67 Q3 Loss Narrows 67 Q3 Loss Widens 67 Completes Dosing 67 Launches Innovative 67 Announces Stockholder Approval 67 Encysive surged 67 Squibb Genentech 67 Stock Downgraded 67 Provides Comprehensive 67 Announce Strategic 67 Little Colds Decongestant Plus 67 Settles Patent Litigation 67 Reports Positive 67 SERVICES INDUSTRY 67 Demonstrates Positive 67 Mylan Receives Approval 67 eigen aandelen 67 Initiates Clinical 67 Canaccord Genuity Reiterates Buy 67 CysDisplay R 67 VP Exercises Options 67 Tata Steel DLF 67 Announces Job Cuts 67 Receives Regulatory 67 Makes Unsolicited Bid 67 Develop Novel 67 Boosts Qtr 67 SHP LN 67 Settles Patent Dispute 67 Voluntarily Withdraws 67 Strengthens Its 67 ASML Novellus Systems 67 Expands Relationship 67 Achieves Milestone 67 Biogen Genentech 67 Granted Orphan Drug 67 Initiates Phase 67 Trend Continues Up 67 Announces Successful Completion 67 Acquires Assets 67 Sinks Lower 67 Awarded Patents 67 Equity Preview 67 Realigns 67 Q4 Profit Surges 67 Licenses Patents 67 Q2 Profit Declines 67 Puts Sold 67 Provide Comprehensive 67 Amend Merger Agreement 67 Declares Common 67 Declares Quarterly Dividends 67 Second Quarter Profit Rises 67 Enters Oversold Territory 67 Q4 Profit Rises 66 Inc. www.micromet inc.com 66 Acquires Controlling Interest 66 Begins Dosing 66 include Healive TM 66 Inc Therapeutic Competitors 66 Announce Expiration 66 FY# Loss Widens 66 Begins Shipment 66 Colaris Colaris AP 66 visit http:/www.PAREXEL.com 66 Finalizes Purchase 66 Acquires Exclusive 66 Larne Holyhead 66 Introduces Innovative 66 Shareholders Approve Sale 66 Drug Fails 66 Completes Merger 66 Enter Into 66 Confirms Commitment 66 PRODUCT SOURCE 66 Achieves Certification 66 Attracting Bullish Investors 66 Rolls Royce Scion 66 Receives Favorable Ruling 66 Receives Approval 66 Unveils Breakthrough 66 3Q Profit Drops 66 Alert Trend Down 66 Presents Positive Preclinical 66 Develop Next Generation 66 Investigates Possible Breach 66 Bearish Engulfing Pattern 66 Idenix Novartis 66 Boehringer Ingelheim Bristol Myers 66 Significantly Reduces 66 Honda Hyundai Kia 66 Commences Cash 66 Inks Pact 66 Other ImmunoGen collaborative 66 By Neil Osterweil 66 Hires Lobbyist 66 Schaeffer Sentiment Snapshot 66 Expands Relationship With 66 2Q Profit Climbs 66 Closes Sale 66 CEO Exercises Options 66 Extends Relationship 66 Q2 Profit Surges 66 Doubletree Embassy Suites Hotels 66 Regains Compliance 66 Alert Technicals Showing Bullish 66 Posts Wider Loss 66 Owen Hargreaves Bayern Munich 66 Narrows Guidance 66 Acquire Assets 66 THE TREND CONTINUES DOWN 66 FDA Approves 66 Announces Favorable 66 Meets Primary Endpoint 66 Shareholders Approve Merger 66 DOWNWARD MOMENTUM LOOKS TO 66 #mins #.#secs M 66 Upside Looming 66 developing Bicifadine serotonin 66 Samsung Sanyo 66 SVP Exercises Options 66 Crossover Alert 66 Launches Groundbreaking 66 Nasdaq AEGR 66 Trend Continues Higher 66 Regains Full 66 Cephalon GlaxoSmithKline Schering Plough 66 Q3 Profit Soars 66 Receives Notification 66 1Q Profit Triples 66 CFO Exercises Options 66 Bearish MACD 66 FINANCE INDUSTRY 66 Upgrade Alert 66 Activity Alert 66 DOWNGRADE ALERT WATCH FOR 66 Introduces Breakthrough 66 Presents Preclinical 66 Closes Buyout 66 SHARES SLIDING LOWER DOWN 66 THE COMPANY TO BE 66 Services #:#-#,# Abstract 66 Launches Unique 66 International SMI SYNN 66 Files Patent Application 66 Receive Milestone Payment 66 Given Outperform Rating 66 THE PHARMACEUTICALS INDUSTRY 66 Willy Sagnol Bayern Munich 66 medic Naseer 66 BAT Diageo 66 Terminate Merger Agreement 66 Oral Suspension USP 66 Reversal Soon 66 Q2 Adj 66 pain relievers Duragesic 66 BULLISH MOVING AVERAGE CROSSOVER 66 Obtains License 66 Reports Preclinical Data 66 Posts Higher 66 pralatrexate injection folate analogue 66 Statin medicines sold 66 Establish Joint Venture 66 Analysts Begin Coverage 66 Deliver Comprehensive 66 Philippe Mexes AS Roma 66 Options Brief 66 Successfully Closes 66 nano particle tumor suppressor 66 CybeRelease Decliners 66 Tibotec BVBA 66 Introduces Revolutionary 66 Announces Immediate Availability 66 Buyers Accumulate Shares 66 molecular therapeutics immunotherapies 66 Subsidiary Acquires 66 NYFCC awarded 66 Introduces Novel 66 developing ACAPODENE 66 Downward Momentum Looks 66 Updates Outlooks 66 OR ACHIEVEMENTS THAT ARE 66 Alastair Cook Essex 66 MONSTERSTOX.COM Monsterstox.com 66 Q1 Profit Declines 66 Second Quarter Earnings Preview 66 Announce Exclusive 66 Traders Hedging Bets 66 Unveils Revolutionary 66 'S SHARES CHANGING 66 Candlesticks Bearish Engulfing 66 Alert Technicals Showing Bearish 66 Inc. Alcortin TM 66 Cloud Cover Pattern 66 Signs Agreements 65 Inks Deal 65 Receives URAC 65 Resumes Coverage 65 G. Profiling 65 Avionics Honeywell 65 2Q Profit Rises 65 Raises Dividend 65 THE HIGHEST FREE 65 Panasonic ReadSoft 65 Hayden Paddon Mitsubishi Lancer 65 Extends Commitment 65 Win Openers 65 Postal Service Verizon ViaMichelin 65 Terminates Contract 65 SET TO POSSIBLY PULLBACK 65 Completes Refinancing 65 1Q Profit Rises 65 Files Patent 65 MARKETING AGREEMENTS PRODUCT SOURCE 65 ENL recurrence 65 Midfielders Xabi Alonso 65 GuruFocus rated 65 Paris IPN Euronext 65 GlaxoSmithKline MedImmune 65 Q4 Loss Widens 65 Announces Redemption 65 TRADING HIGHER ON #.#X 65 Buys Majority Stake 65 Announces Publication 65 Corporation Ridgefield CT 65 Author Affiliation 65 Mathijsen Giovanni van Bronckhorst 65 KLA Tencor Lam 65 AS CALL VOLUME 65 Attains 65 Completes Purchase 65 Jointly Promote 65 BUYERS ACCUMULATE SHARES OF 65 Shareholders Approve Merger Agreement 65 Awarded Qualifying Therapeutic 65 NASDAQ MNKD focuses 65 Gets Approval 65 Stays Neutral 65 Releases Latest 65 Q3 Profit Declines 65 Signs Merger Agreement 65 Drug Shows Promise 65 STOCK ON 65 Merck Serono Ortho Clinical 65 Announces Commencement 65 markets COLAZAL 65 RELATIVE PERFORMANCE 65 APS Healthcare Corphealth 65 SMARTREND DETECTS CONTINUED BUYING 65 Citi Downgrades 65 NYSE PFE Exelon Rivastigmine 65 STERIS Corporation Announces 65 BY JANETTE FOR 65 Restructures Operations 65 EMC Emulex 65 Profit Climbs 65 Inc. NASDAQ SIRT 65 COO Exercises Options 65 IPCA Laboratories 65 Ups Guidance 65 TradeSignals 65 include ClindaReach TM 65 drug Galvus Sanofi 65 Uptrend Spotted 65 Quarterly Profit Rises 65 Receives NASDAQ 65 Myriad logo BRACAnalysis 65 Posts Large 65 Q3 Adj 65 Receives Accreditation 65 Regains Compliance With 65 Board Authorizes 65 Receives Certification 65 3Q Profit Falls 65 Fortis Generali Groupama 65 Board Unanimously Rejects 65 Achieves Oracle Validated 65 Guides Inline 65 1Q Profit Falls 65 Q4 Profit Declines 65 THEY SAY THE 65 PRICE TO 65 FALLS BELOW 3 65 Announces Voluntary Recall 65 2Q Profit Up 65 Bullish Technical Alert Trend 65 Shows Promise 65 Completes Buyout 65 Stocks Fall Paced 65 iDotz.Net domain registrar 65 Settle Litigation 65 Endures Analyst Downgrade 65 4Q Profit Up 65 Commences Tender Offer 65 Demonstrates Significant 65 FY# Profit Rises 65 ANALYST RATING FLASHBACK 65 Declares Fourth Quarter 65 Submits Proposal 65 4Q Profit Drops 65 Konica Minolta Kyocera 65 Announces Positive 65 Sellers Distribute Shares 65 THE SERVICES SECTOR 65 Purchases Moore Microprocessor 65 includes Dideco CarboMedics 65 BUYERS ACCUMULATING SHARES OF 65 Increases Quarterly Dividend 65 UPWARD MOMENTUM LOOKS TO 65 Announces Dismissal 65 Enters Strategic 65 Discount Cialis Cialis 65 PRESSURE IN SHARES OF 65 TODAY HIGH LOW 65 THE TREND CONTINUES UP 65 By TIMOTHY LE 65 Initiates Phase 2b 65 By Sylvie Belmond 65 Shows Bullish Technicals 65 Plans Job Cuts 65 particularly SANCTURA XR 65 Complete Merger 65 Lowers Price 65 Announces Additions 65 3Q Profit Up 65 THE TREND CONTINUES LOWER 65 DOWNTREND CALL 65 By MATT KATZ 65 Inc. Nasdaq OXGN 65 Increases Stake 65 PAN AMERICAN AND ITS 65 Author Affiliations Division 65 Announces Stock Repurchase 65 Exercises Option 65 tranquilizers diazepam 65 By FRANK MUNGER 65 Significantly Improves 65 Subsidiary Awarded 65 MANAGEMENT CHANGES SOURCE 65 IS TALKING ABOUT 65 Ink Deal 65 Movers roundup 65 Declares Second Quarter 65 Staphylococcus aureus Immune Globulin 65 Transgenomic Pharmacogenomics Services 65 JVC Kodak 65 Shareholders Approve 65 Achieves ISO #:# Certification [002] 65 Q4 Profit Soars 65 CONFERENCE CALLS EARNINGS SOURCE 65 NATIONAL ECONOMIC COUNCIL DIRECTOR 65 Am J Obstet 65 THE UNDERLYING FUTURE 65 CHEAP ONLINE PHARMACY BEST 65 Confirms Receipt 65 ON 1X ABOVE AVERAGE 65 Net Loss Narrows 65 OR ACHIEVEMENTS IMPLIED 65 including Bayer Celldex 65 Wins Prestigious 65 Announces Enhancements 65 Begins Shipping 65 Ovitrelle R Serostim 65 Achieves Prestigious 65 Sign Definitive Merger 65 Shares Creeping Higher 65 Mali Mauritius Mozambique 65 Initiates Clinical Trials 65 Maintains Buy Rating 65 Closes Acquisition 65 BOVESPA ETER3 65 overname 65 Releases Latest Version 65 Owens Corning Syngenta 65 Author Affiliations 65 Reiterates Hold Rating 65 sanofi aventis Novartis 65 Announces Formation 65 THE TREND CONTINUES HIGHER 65 Receives Positive 65 Announces Shareholder Approval 65 Novartis Biogen Idec 65 DAY PATTERN FOR 65 Directors Unanimously Rejects 65 Acquires Majority Stake 65 Seeks Approval 65 Award Recognises 65 Rejects Takeover Bid 65 Canaccord Genuity Maintains Buy 65 Completes Asset 65 TO REBOUND AFTER 65 % pramoxine HCl 65 orderonlinecialis 65 BY MARK ARSENAULT 65 PRINCE CASPIAN REVIEW 65 Initiate Phase III 65 Unveils Newest 65 Upside Purchased 65 THE COMPANY 'S STRATEGIES 65 ALONG WITH OTHER 65 Enters Into Agreement 65 Reiterates Buy Rating 65 Significantly Expands 65 Commences Phase 65 Hindalco HLL 65 Novel Oral 65 Wins Summary Judgment 65 Approve Merger 65 GlaxoSmithKline Bristol Myers 65 Warwickshire Ravi Bopara 65 REM Scissor Sisters 65 Announce Partnership 65 Wins Prestigious Award 65 WATCH FOR CONTINUED GAINS 65 Shares Climb 65 Sweetens Bid 65 Showcases Latest 65 Osteoporosis Drug 65 BellwetherReport.com Analyst Report 64 Expects Higher 64 LSE SHP.L 64 Reports Double Digit 64 Reinforces Importance 64 Spins Out 64 SERVICES INDUSTRY WITH 64 Vitrasert R 64 Profit Increases 64 SRZ GY 64 Smit capt 64 Announces Webcast 64 Settles Dispute With 64 WEEK HIGH RECENTLY ECLIPSED 64 www.bharatbook.com 64 SHARES UP 64 GOES FROM 64 Announces Departure 64 #/#/# PriceWatch Alert Technicals [003] 64 Single Dose 64 Completes Sale 64 Raises Bid 64 Awarded Patent 64 Scott Lathram pilot 64 Zacks Analyst Interview 64 pharmacogenomic translational research 64 Shares Surge 64 TRADERS RIDE THE 64 Releases Enhanced 64 Terminates Merger Agreement 64 MGM Miramax 64 TO POTENTIALLY PULLBACK AFTER 64 Sirna Therapeutics StrataCom 64 Detects Unusual Activity 64 Completes Reorganization 64 Taglich Brothers Initiates Coverage 64 1Q Profit Surges 64 SIGNING LOW OF 64 Outbids 64 SPOKE TO HER MOTHER 64 Julien Escude Sevilla 64 Other OTC MNDP 64 Deliver Presentation 64 & Sullivan Lauds 64 Enters Into Strategic 64 Crofelemer budesonide foam 64 SWOT Analysis http:/www.companiesandmarkets.com aJEH MacDonald 64 Expands Scope 64 RELEASES ITS QUARTERLY NUMBERS 64 Matt Kenseth Truex 64 Maintains Hold Rating 64 Posts Wider 64 Boosts Profit 64 Rebrands 64 Reaffirms Outlook 64 Awarded Prestigious 64 Announces Expiration 64 Completes Integration 64 Syneron logo 64 PROSPECTUS PROXY STATEMENT BECAUSE 64 Announces Effective Date 64 Makes Hostile Bid 64 Lowers Guidance 64 Invites Investors 64 Lockheed Martin Ingersoll Rand 64 Amvescap PLC UK 64 palonosetron hydrochloride Injection Dacogen 64 OR ACHIEVEMENTS TO BE 64 markets XIFAXAN ® 64 Lowers Estimates 64 Closes Previously Announced 64 1Q Profit Up 64 L.L.C. v. 64 SIX RO ROG 64 Put Volume Surges 64 OTHER THAN PURELY HISTORICAL 64 Renews Relationship 64 Inks Agreement 64 Unveils Groundbreaking 64 Biogen Idec Biotest Genentech 64 Announces Dosing 64 By JASON LAUGHLIN 64 folgenden Meldung ist nicht 64 Novartis Sanofi Aventis 64 #/#/# PriceWatch Alert Technicals [001] 64 Range Tightening 64 Initiates Voluntary Recall 64 REACHES INITIAL SUPPORT LEVEL 64 Procures 64 Dividend Yield Outperforms 64 FY# Loss Narrows 64 NEEDS WHICH MAY CAUSE 64 acute peptic ulcer 64 USP Tablets PEPCID 64 Posts Narrower Loss 64 FDA Okays 64 Conference Call TRANSCRIPT 64 THAT MAKE THE COMPANY 64 FOR SHARES OF 64 INDICATED HIGHER 64 3Q Profit Surges 64 Inc. www.coopersurgical.com develops 64 aaron.gray block @ thomsonreuters.com 64 Gets Favorable 64 Posts Large Volume 64 Jaiprakash Associates HDFC 64 MOUNTAIN VIEWS 64 VOLUME ARE SHARES OF 64 Genentech Boehringer Ingelheim 64 Awarded Contract 64 Service Computerworlds internasjonale nyhetsbyrå 64 Andrew Flintoff capt 64 TRISCUIT crackers 64 Racing #.#secs 64 Extend Partnership 64 please visit http:/www.vandapharma.com 64 Q1 Profit Decreases 64 Posts Wider 4Q Loss 64 Remains Neutral 64 STMicroelectronics Texas Instruments 64 Unveils Upgraded 64 Morning Movers 64 Successfully Integrates 64 CONTINUES UP 64 EVP Exercises Options 64 Completes Recapitalization 64 markets HP Acthar 64 WHEN YOU WERE DOWN 64 Announces Dividend 64 BUY CHEAPEST PILLS ONLINE 64 By LOLA ALAPO 64 SHARES COULD POTENTIALLY PULLBACK 64 GSK CSL 64 Webcast Annual Meeting 64 Completes Previously Announced 64 Secures Long Term 64 Vaccine Adjuvant 64 Unusual Trading 64 SHARES CREEPING HIGHER UP 64 Third Quarter Profit Rises 64 Q4 Profit Plunges 64 please visit www.dsi.com 64 Acquires Remaining Interest 64 SCHWARB 64 Secures Financing 64 Announces Revised 64 Hargreaves Bayern Munich 64 ALSO CALLED 64 Rated Speculative Buy 64 AMEX NVD specialty 64 SPECULATE ON HIGHER PRICES 64 IN RETROSPECT SHARES 64 INFORMATION TECHNOLOGY EQUIPMENT 64 sanofi aventis GSK 64 THE LOWEST RELATIVE PERFORMANCE 64 Posts 1Q Profit 64 Boosts Productivity 64 Sells Shares 64 BNP Paribas Banco Santander 64 By Megan Ainscow 64 #/#/# PriceWatch Alert Technicals [002] 64 HOT STOCKS 64 PATTERN FOR 64 3Q Profit Jumps 64 Huntelaar Ajax 64 Magazine Recognizes 64 Marc Planus Bordeaux 64 Announces Termination 64 Announces Recapitalization 64 Announces Issuance 64 Une sélection d' 64 THEY REVIEWED 64 Announces Affiliation 64 Announces Availability 64 AstraZeneca AZN.L 行情 64 Passengers retrieving 64 Stocks Climb Paced 64 SUSPENDED OR REVOKED LICENSE 64 CALL VOLUME UP 64 Luveris R Ovidrel R 64 Endoscopy Laparoscopy 64 Beckman Coulter Biomerieux Ortho 64 novel orally inhaled 64 Takeda Kyowa Hakko Kirin 64 Zacks Earnings Preview 64 SABER ™ 64 Bullish Engulfing Formed 64 Netherlands Ziggo T 64 By DAN MORAN 64 Shows Bearish Technicals 64 Receives Orphan Drug 64 Guides FY# Quick Facts 64 NOTE POSIDUR ™ 64 failure thrombosis embolism 64 Subsidiary Enters 64 Inc. Attracting Bullish 64 commercialize Dimebon 64 Reaches Initial Support 64 NEC Nokia Siemens 64 Swisscom Telecom Italia 64 CHEAP DRUGS BEST ONLINE 64 TRADERS HEDGING BETS IN 64 Novell Veritas Vignette 64 Stocks Climb Led 64 Reaffirms Earnings 64 Announces Expanded 64 EARNINGS REVIEW 64 NEWS RELEASE THE COMPANY 64 Ups Stake 64 Maintains Neutral Rating 64 Unveils Enhanced 64 READ THE DEFINITIVE 64 Reiterates Buy 64 TO DEVELOP 64 Receives Prestigious Award 64 Sets Quarterly Dividend 64 Sybase Symantec 64 weakness dizziness headache 64 Q1 Profit Soars 64 Improves Efficiency 64 N.V. 64 HAS RETURNED 64 ECONOMIC EVALUATIONS AND 64 Madagascar Mali Mauritania 64 FDA Approves Novel 64 cladribine Cladribine Tablets 64 Joins OTCQX 64 ¢ ÃÆ'à † â 64 ONCE THEY 64 IS NOT SUITABLE FOR 64 Seeking Direction 64 THAT ALLOWS 64 Clinical Trial Evaluating 64 More Than Triples 64 PRN4 64 orderonlineviagra 64 SMARTREND 64 BioClinica supports 64 Nissan Seat Skoda 64 BY SUCH STATEMENTS 64 TRANSDUR ® 64 Telecom Italia Telefónica 64 Net Loss Widens 64 VOLUME WATCH FOR 64 Shows Promising 64 OR REFLECT THE 64 gets USFDA nod 64 4Q Profit Falls 64 SPEARCE@ENQUIRER.COM 64 Closes Merger 64 Company NASDAQ SKBI 64 Declares Regular Quarterly Dividend 64 TO POTENTIALLY REBOUND AFTER 64 Signs Long Term 64 Sterlite Cairn 64 3hours #mins #.#secs M 64 Signs Agreement 64 Awarded Multi 64 JAK2 Inhibitor 64 ChevronTexaco Dow Chemical 64 4Q Profit Doubles 64 AS PUT VOLUME 64 4th Qtr Profit Rises 64 VOLUME WATCH FOR POTENTIAL 64 REGULATIONS AND 64 Awarded Contracts 64 Revitalizes 64 % # BTO 64 4Q Profit Surges 64 BEARISH MOVING AVERAGE CROSSOVER 64 Extend Relationship 64 & Sullivan Recognizes 64 Equipment Deals 64 UNCERTAINTIES AND OTHER FACTORS 64 otcstockexchange.com 64 WERE YOU SURPRISED 64 Posts Strong 64 Enteral Feed Devices 64 THE MATERIALS AND 64 Drug Candidate 64 Holds Annual Meeting 64 Profits Rise 64 Announces Acquisition 64 NYSE CAL Luxair 64 Forges Partnership 64 LOOKING STATEMENTS CAN BE 64 Announces Share Repurchase 64 MARKETING AGREEMENTS SOURCE 64 Universal Pandemic Influenza 64 Sentiment Snapshot 64 Guides Below 64 Announces Sponsorship 64 CRWEWallstreet.com Stock Report 64 THIS WILL LEAD 64 Goalkeepers Gianluigi Buffon 64 tleys@dmreg.com 64 Completes Transaction 64 OFF CAPS LOCK 64 Earns Accreditation 64 Achieves Significant 64 Diagnostic Imaging Devices 64 Provides Detailed 64 BIOTECHNOLOGY SOURCE 64 Trims Loss 64 sont publiés sur ReliefWeb 64 Forms Joint Venture 64 Receives CE Marking 64 MOMENTUM LOOKS TO CONTINUE 64 Defenders Eric Abidal 64 Raises Forecast 64 Awarded GSA Schedule 64 under ticker DOCK 64 Looks Bullish 64 Boosts Quarterly Dividend 64 REPORT ITS QUARTERLY 64 Reconfirms 64 Pharmaceuticals GHI 64 SET TO PULLBACK AFTER 64 Secures Funding 64 By BOB AUDETTE 64 4Q Profit Rises 64 Wins Contract 64 Exec Exercises Options 64 AND TRY TO 64 OCCURRENCE OF UNANTICIPATED EVENTS 64 Jermaine Jenas Tottenham 64 Receives Prestigious 64 Highest Upside 64 Monoprix PETCO Safeway 64 intermittent monsoon rains 64 Third Quarter Earnings Preview 64 WHICH MAY CAUSE 64 platform HDL Mimetic 64 AstraZeneca Sanofi Aventis 64 Revises Guidance 64 声明 64 PULLBACK IN SHARES OF 64 SAID AND 64 celery pumpkin pie